Coronary ischemia related to alemtuzumab therapy

被引：16

作者：

Basquiera, AL ^{[1
]}

Berretta, AR ^{[1
]}

García, JJ ^{[1
]}

Palazzo, ED ^{[1
]}

机构：

[1] Hosp Privado Ctr Med Cordoba, Dept Hematol & Oncol, Cordoba, Argentina

来源：

ANNALS OF ONCOLOGY | 2004年 / 15卷 / 03期

关键词：

D O I：

10.1093/annonc/mdh114

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：539 / 540

页数：2

共 5 条

[1] Severe cardiac toxicity after monoclonal antibody therapy [J].

Damaj, G ;

Rubio, MT ;

Audard, V ;

Hermine, O .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 68 (05) :324-324

[2] Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study [J].

Keating, MJ ;

Flinn, I ;

Jain, V ;

Binet, JL ;

Hillmen, P ;

Byrd, J ;

Albitar, M ;

Brettman, L ;

Santabarbara, P ;

Wacker, B ;

Rai, KR .

BLOOD, 2002, 99 (10) :3554-3561

[3] Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL) [J].

Lundin, J ;

Kimby, E ;

Björkholm, M ;

Broliden, PA ;

Celsing, F ;

Hjalmar, V ;

Möllgård, L ;

Rebello, P ;

Hale, G ;

Waldmann, H ;

Mellstedt, H ;

Österborg, A .

BLOOD, 2002, 100 (03) :768-773

[4] Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine [J].

Rai, KR ;

Freter, CE ;

Mercier, RJ ;

Cooper, MR ;

Mitchell, BS ;

Stadtmauer, EA ;

Santábarbara, P ;

Wacker, B ;

Brettman, L .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) :3891-3897

[5] Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an Anti-CD20 monoclonal antibody (Rituximab, IDEC-C2B8) [J].

Winkler, U ;

Jensen, M ;

Manzke, O ;

Schulz, H ;

Diehl, V ;

Engert, A .

BLOOD, 1999, 94 (07) :2217-2224

← 1 →